OpenClinica chosen for use in Cardiovascular Clinical Trials

Global producer of cardiovascular therapies looks to commercial open source software to support key clinical research.

OpenClinica, LLC announces that TriReme Medical, a global producer of therapies for complex vascular disease, has selected the OpenClinica Enterprise Edition to enhance data collection and management in its clinical research.

TriReme Medical is a global company engaged in the design, manufacture, and distribution of advanced therapeutic solutions for the treatment of complex vascular disease. Their products include minimally invasive coronary and peripheral devices offering physicians new and differentiated tools to improve outcomes in complex peripheral and coronary interventions.

OpenClinica, LLC is the leading provider of commercial open source software for clinical trial electronic data capture and clinical data management. “OpenClinica’s flexible model makes it easy for us obtain a regulatory compliant environment in which to collect and manage data for our pivotal clinical research,” said Erin Tims, Associate Director, Clinical Affairs.